Distinct Predictors of Clinical Response after Repetitive Transcranial Magnetic Stimulation between Bipolar and...

Area of Science:

• Neurology
• Psychiatry
• Neuroscience

Background:

• Repetitive transcranial magnetic stimulation (rTMS) is a proven therapy for drug-resistant depression.
• Differentiating between bipolar and unipolar depression is crucial for tailoring rTMS treatments.
• Predicting treatment response in distinct depressive subtypes can optimize patient outcomes.

Purpose of the Study:

• To identify predictors of clinical improvement one month after rTMS in bipolar and unipolar depression.
• To compare clinical conditions between bipolar and unipolar depression patients undergoing rTMS.
• To establish diagnostic-specific factors for predicting rTMS efficacy.

Main Methods:

• Utilized data from a previous study involving 291 patients with depression.
• Compared clinical conditions between bipolar and unipolar patient groups.
• Analyzed factors predicting one-month clinical improvement (M1) post-rTMS for each diagnostic group.

Main Results:

• Bipolar patients showed fewer responders but better sustained improvement in anxiety and illness perception compared to unipolar patients.
• In bipolar depression, young age, fewer medications, and high fatigue predicted M1 improvement.
• In unipolar depression, longer current depressive episode duration and being 'attached' predicted M1 improvement.

Conclusions:

• Specific predictive factors for rTMS response were identified for both bipolar and unipolar depression.
• These findings can enhance the prediction of rTMS efficacy in clinical neuromodulation settings.
• Personalized treatment strategies based on diagnostic-specific predictors can improve rTMS effectiveness.